Correlation Between BB Biotech and Lyxor MSCI

Can any of the company-specific risk be diversified away by investing in both BB Biotech and Lyxor MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Lyxor MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BB Biotech AG and Lyxor MSCI India, you can compare the effects of market volatilities on BB Biotech and Lyxor MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Lyxor MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Lyxor MSCI.

Diversification Opportunities for BB Biotech and Lyxor MSCI

-0.29

Correlation Coefficient

BB Biotech  Lyxor MSCI

Very good diversification

The 3 months correlation between BION and Lyxor is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Lyxor MSCI India in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyxor MSCI India and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Lyxor MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyxor MSCI India has no effect on the direction of BB Biotech i.e., BB Biotech and Lyxor MSCI go up and down completely randomly.

Pair Corralation between BB Biotech and Lyxor MSCI

Assuming the 90 days trading horizon BB Biotech AG is expected to generate 1.49 times more return on investment than Lyxor MSCI. However, BB Biotech is 1.49 times more volatile than Lyxor MSCI India. It trades about -0.03 of its potential returns per unit of risk. Lyxor MSCI India is currently generating about -0.11 per unit of risk. If you would invest  3,760  in BB Biotech AG on September 14, 2024 and sell it today you would lose (110.00) from holding BB Biotech AG or give up 2.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BB Biotech AG  vs.  Lyxor MSCI India

BB Biotech AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Lyxor MSCI India

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lyxor MSCI India has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Lyxor MSCI is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with BB Biotech and Lyxor MSCI

The main advantage of trading using opposite BB Biotech and Lyxor MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Lyxor MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyxor MSCI will offset losses from the drop in Lyxor MSCI's long position.

The idea behind BB Biotech AG and Lyxor MSCI India pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.